Bilimsel çalışmalar
Uzm. Dr. Ferda Can
61 yayın. Her yayının yanında bilginin kaynağı yazar.
-
Prognostic Differences Between P190 and P210 BCR::ABL1 in Patients with Philadelphia-Positive B-cell Acute Lymphoblastic Leukemia
Indian Journal of Hematology and Blood Transfusion, 2026
DOI 10.1007/s12288-025-02095-8 PMID 41522562 Açık erişimli tam metinKaynak: ORCID
-
Olgular Eşliğinde Erişkin Hematoloji
Akademisyen Kitabevi eBooks, 2026
DOI 10.37609/akya.4308 Açık erişimli tam metinKaynak: OpenAlex
-
Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review
Leukemia Research, 2026
DOI 10.1016/j.leukres.2026.108239 PMID 42090741 Kaynak: OpenAlex
-
Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study
Leukemia Research, 2026
DOI 10.1016/j.leukres.2026.108342 PMID 42933070 Kaynak: OpenAlex
-
Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry
Journal of Clinical Medicine, 2025
DOI 10.3390/jcm14207367 PMID 41156238 Açık erişimli tam metinKaynak: OpenAlex
-
AML-556: Personalized Therapy and Real-World Outcomes in Adult Acute Myeloid Leukemia: Lessons From a Nationwide Prospective Cohort in Turkey
Clinical Lymphoma Myeloma & Leukemia, 2025
DOI 10.1016/s2152-2650(25)01691-x Kaynak: OpenAlex
-
POSTER: AML-556 Personalized Therapy and Real-World Outcomes in Adult Acute Myeloid Leukemia: Lessons From a Nationwide Prospective Cohort in Turkey
Clinical Lymphoma Myeloma & Leukemia, 2025
DOI 10.1016/s2152-2650(25)00540-3 Kaynak: OpenAlex
-
Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project
BMC cancer, 2025
DOI 10.1186/s12885-025-14987-z PMID 41073967 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC
-
HL-1088: Primary Hodgkin Lymphoma of the Stomach
Clinical Lymphoma Myeloma & Leukemia, 2025
DOI 10.1016/s2152-2650(25)02212-8 Kaynak: OpenAlex
-
Türkiye Klinikleri
AYBU AVESIS, 2025
Kaynak: OpenAlex
-
JİNEKOLOJİK CERRAHİLERDE KANAMA YÖNETİMİ
AYBU AVESIS, 2025
Kaynak: OpenAlex
-
INTERVENTIONAL PROCEDURE IN HEMOPHILIA A PATIENT WITH EXTENDED HALF-LIFE FACTOR THERAPY- CIRCUMCISION- CASE REPORT
Hematology Transfusion and Cell Therapy, 2024
DOI 10.1016/j.htct.2024.11.044 Açık erişimli tam metinKaynak: OpenAlex
-
BEVACİZUMAB İLE MÜKEMMEL YANIT MÜMKÜN MÜ?
AYBU AVESIS, 2024
Kaynak: OpenAlex
-
Real-Life Use of Asciminib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Results of the Turkish Managed Access Program
Blood, 2024
DOI 10.1182/blood-2024-202019 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex
-
Hematological diseases and the heart
Turkish journal of medical sciences, 2024
DOI 10.55730/1300-0144.5929 PMID 39735486 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC
-
Prognostic value of hyperlactatemia and lactate clearance in septic patients with hematological malignancies
Annals of Hematology, 2024
DOI 10.1007/s00277-024-05977-5 PMID 39235491 6 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex
-
Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Refractory Multiple Myeloma
Nigerian Journal of Clinical Practice, 2024
DOI 10.4103/njcp.njcp_107_24 PMID 40033534 2 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex
-
EFFECT OF HEREDITARY THROMBOPHILIA ON ARTERIAL THROMBOSIS
Hematology Transfusion and Cell Therapy, 2024
DOI 10.1016/j.htct.2024.04.006 Açık erişimli tam metinKaynak: OpenAlex
-
HARMONIZATION OF TREATMENT APPROACHES: DRAWING INSPIRATION FROM PEDIATRIC TREATMENTS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA THERAPY
Hematology Transfusion and Cell Therapy, 2024
DOI 10.1016/j.htct.2024.11.105 Açık erişimli tam metinKaynak: OpenAlex
-
Miyelodisplastik Sendromda Venetoklaks Tedavisi Gerçek Yaşam Verisi: Türk Hematoloji Derneği Lösemi Çalışma Grubu
AYBU AVESIS, 2024
Kaynak: OpenAlex
-
Erişkin Hematolojisinde Pratik Konsültasyon Yaklaşımları
AYBU AVESIS, 2024
Kaynak: OpenAlex
-
Primer Kutanöz Marjinal Zon Lenfoma
AYBU AVESIS, 2024
Kaynak: OpenAlex
-
Prospective Real-World Outcomes of Acute Myeloid Leukemia
Blood, 2023
DOI 10.1182/blood-2023-182800 Açık erişimli tam metinKaynak: OpenAlex
-
Ibrutinib combined with gemcitabine-vinorelbine for primary refractory non-Hodgkin lymphoma
Blood Research, 2023
DOI 10.5045/br.2023.2023182 PMID 37964656 Açık erişimli tam metinKaynak: ORCID
-
Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data
Annals of Hematology, 2023
DOI 10.1007/s00277-023-05344-w PMID 37432415 Kaynak: ORCID
-
LENF NODU BİYOPSİSİNDE KRONİK LENFOSİTİK LÖSEMİ, PROSTAT KANSERİ BİRLİKTELİĞİ; VAKA SUNUMU
AYBU AVESIS, 2023
Kaynak: OpenAlex
-
DAMAR YOLUYLA UYGULANAN FARKLI DEMİR TEDAVİLERİNİN TOPLAM OKSİDAN VE ANTİOKSİDAN YÜK ÜZERİNE ETKİSİNİN KARŞILAŞTIRILMASI, TEK MERKEZ VERİSİ
AYBU AVESIS, 2023
Kaynak: OpenAlex
-
Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2023
DOI 10.4274/tjh.galenos.2023.2023.0194 PMID 37877113 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC
-
A Giant Mass in the Eyelid: Peripheral T-Cell Lymphoma, Not Otherwise Specified
Journal of Current Ophthalmology, 2023
DOI 10.4103/joco.joco_314_22 PMID 37680280 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex
-
Perioperative Management of Patients with Rare Congenital Factor Deficiency
Eurasian Journal of Medical Investigation, 2023
DOI 10.14744/ejmi.2023.75606 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex
-
Idarubicin Versus Daunorubicin Versus Mitoxantrone for Induction Chemotherapy in Acute Myeloid Leukemia: Patient Registration Study of Turkish Society of Hematology-Acute Myeloid Leukemia Working Group
Blood, 2023
DOI 10.1182/blood-2023-187351 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex
-
Darbepoietin Alfa Treatment in Myelodysplastic Syndrome: Single Center Data
LLM Dergi, 2023
DOI 10.5578/llm.20229905 Açık erişimli tam metinKaynak: OpenAlex
-
Opioid Administration for Mucositis-related-Pain Using Patient Controlled Analgesia (PCA) Method is Associated with the Development of Early Posttransplant Complications
Acta Oncologica Turcica, 2023
DOI 10.5505/aot.2023.87360 Açık erişimli tam metinKaynak: OpenAlex
-
MDS-143 Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study
Clinical Lymphoma Myeloma & Leukemia, 2023
DOI 10.1016/s2152-2650(23)01166-7 Kaynak: OpenAlex
-
POSTER: MDS-143 Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study
Clinical Lymphoma Myeloma & Leukemia, 2023
DOI 10.1016/s2152-2650(23)00580-3 Kaynak: OpenAlex
-
Salvage Autologous Hematopoietic Stem Cell Transplantation Versus Chemoimmunotherapy in Relapsed Multiple Myeloma Patients After First Transplantation; Single Center Data
Journal of Ankara University Faculty of Medicine, 2023
DOI 10.4274/atfm.galenos.2023.83713 Açık erişimli tam metinKaynak: OpenAlex
-
CHARACTERİSTİCS AND OUTCOMES OF MYELODYSPLASTİC SYNDROME PATİENTS TREATED WİTH DARBEPOETİN ALFA FOR ANEMİA İN TURKEY: A MULTİCENTER RETROSPECTİVE STUDY
Kocaeli Üniversitesi - AVESİS, 2023
Kaynak: OpenAlex
-
Hiperviskoziteye bağlı vajinal kanama ile tanı konulan plazma hücreli lösemi olgusu
AYBU AVESIS, 2023
Kaynak: OpenAlex
-
HİPERFERRİTİNEMİ KATARAKT SENDROMU: OLGU SUNUMU
AYBU AVESIS, 2023
Kaynak: OpenAlex
-
Gebelikte Onkolojik Yaklaşımlar
Akademisyen Kitabevi eBooks, 2022
DOI 10.37609/akya.1656 Kaynak: OpenAlex
-
Retrospective Analysis of Turkish AML Registry Database, on Behalf of AML Working Group of Turkish Society of Hematology
Blood, 2022
DOI 10.1182/blood-2022-167639 Kaynak: OpenAlex
-
COVID-19 Disease in Patients with Hematological Disease-Single Center Data
Journal of Ankara University Faculty of Medicine, 2022
DOI 10.4274/atfm.galenos.2021.09825 Açık erişimli tam metinKaynak: ORCID
-
The effects of plasma viscosity in thromboembolic events among patients with essential thrombocytosis: A case-control study
Clinical Hemorheology and Microcirculation, 2022
DOI 10.3233/ch-211137 PMID 34602461 2 atıf (Europe PMC) Kaynak: ORCID
-
Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine
Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022
DOI 10.4274/tjh.galenos.2021.2021.0537 PMID 34886748 4 atıf (Europe PMC) Açık erişimli tam metinKaynak: Europe PMC
-
Comparison of daily oral iron replacement therapy with every other day treatment in female reproductive age patients with iron-deficiency anemia
Annals of Hematology, 2022
DOI 10.1007/s00277-022-04835-6 PMID 35460388 8 atıf (OpenAlex) Kaynak: OpenAlex
-
Standart Prophylactic Granulocyte Colony Stimulating Factor Usage As A Part Of Autologous Stem Cell Transplantation Procedure
Acta Oncologica Turcica, 2022
DOI 10.5505/aot.2022.47113 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex
-
İLAÇSIZ İYİLİK DURUMU KRONİK MİYELOİD LÖSEMİ HASTALARINDA HEDEF OLMALIDIR: İİ-KMLTR (VEYA TKİNDURTÜRK) İLK SONUÇLAR
Kocaeli Üniversitesi - AVESİS, 2022
Kaynak: OpenAlex
-
Pregnancy And Hematologic Diseases
AYBU AVESIS, 2022
Kaynak: OpenAlex
-
Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies
Turkish Journal of Hematology, 2021
DOI 10.4274/tjh.galenos.2021.2021.0287 PMID 34521187 7 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex
-
Hypofibrinogenemia caused by tigecycline use in a patient with acute cholecystitis: a case report and review of the literature
The European Research Journal, 2021
DOI 10.18621/eurj.693536 1 atıf (OpenAlex) Açık erişimli tam metinKaynak: ORCID